Literature DB >> 1406046

Murine survival of lethal irradiation with the use of human umbilical cord blood.

N Ende1, N M Ponzio, R S Athwal, M Ende, D C Giuliani.   

Abstract

We have found that human umbilical cord blood (HUCB) will routinely protect mice exposed to lethal levels of irradiation. At the end of 50 days, over seventy percent (70%) of mice injected with HUCB survived 900 cGy or irradiation, which produced 100% deaths in the uninjected control animals. Moreover, there was some evidence that human colony stimulating factors further improved survival. Anti-Natural Killer cell (NK) antibody was utilized along with HUCB in these studies, however, Anti-NK cell serum alone had no radioprotective effect in mice. The studies reported here suggest the possibility of utilizing HUCB for immediate protection of humans from lethal irradiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1406046     DOI: 10.1016/0024-3205(92)90013-f

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.

Authors:  Andrea L DiCarlo; Radia Tamarat; Carmen I Rios; Marc Benderitter; Christine W Czarniecki; Theresa C Allio; Francesca Macchiarini; Bert W Maidment; Jean-Rene Jourdain
Journal:  Radiat Res       Date:  2017-06-12       Impact factor: 2.841

2.  Human umbilical-cord-blood mononucleated cells enhance the survival of lethally irradiated mice: dosage and the window of time.

Authors:  Olga A Kovalenko; Edouard I Azzam; Norman Ende
Journal:  J Radiat Res       Date:  2013-06-21       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.